About Psychiatric Drugs Side-Effects
About Psychiatric Drugs Side-Effects
About Psychiatric Drugs Side-Effects
Search for: What are the two most common side effects of antipsychotic medications?
What are the common side effects of psychotropic drugs?
Side effects
blurred vision.
nausea.
vomiting.
trouble sleeping.
anxiety.
drowsiness.
weight gain.
sexual problems.
06-Nov-2019
Search for: What is the possible long term side effect of antipsychotic medication?
Do antipsychotics destroy the brain?
Scientific article: Neuroleptic (antipsychotic) drugs may cause cell death. This medical
research revealed that the neuroleptics (also known as antipsychotics) may not only
shrink the brain, but cause actual cell death.15-Sept-2007
Does long term use of psychiatric drugs cause more harm than good?
https://www.ncbi.nlm.nih.gov › articles › PMC4707562
Brain changes in people never medicated for mental illness and ...
https://mentalillnesspolicy.org › myths › medications
PDF
All medications have side effects. Side effects can be harmful or not depending on
the medication, dose and characteristics of individual such as overall health ...
https://www.mind.org.uk/information-support/drugs-and-treatments/antipsychotics/side-effects/
https://www.cchr.org/quick-facts/psychiatric-drugs-side-effects.html
https://www.bmj.com/content/349/bmj.g5312/rr/775731
Rapid Response:
Yaffe, Boustani and Fairbanks (1) commented on a carefully conducted study that showed that
exposure to benzodiazepines doubled the risk of developing Alzheimer’s disease. They found it
likely that use of benzodiazepines lead to permanent brain damage, which they called
neurodegenerative disease. My preference is to call a spade for a spade, which is more easily
understood by the patients. It is less clear that we talk about a drug induced harm if we call it a
“disease”.
Yaffe, Boustani and Fairbanks also say - without any references - that depression and anxiety are
considered risk factors for Alzheimer’s disease. However, the studies psychiatrists usually refer
to when they make such claims do not hold water. A prominent Danish depression researcher
recently mentioned in an article, that antidepressant treatment might possibly reduce the doubled
risk of dementia in people who have previously had depression (2). He referred to a meta-
analysis (3), which is quite typical for the research in this area. It didn’t say anything about
earlier treatment and there wasn’t the least consideration that the increased risk could be caused
by the antidepressant drugs the patients had received.
We know that antipsychotics shrink the brain in a dose-dependent manner (4) and
benzodiazepines, antidepressants and ADHD drugs also seem to cause permanent brain damage
(5). Leading psychiatrists and the drug industry usually say that it is the disease that destroys
people’s brain, but it is very likely the drugs that do it, which also animal studies have found.
This is an important reason why I advocate that we should use psychiatric drugs very little, and
mostly in the acute phase, if people are seriously disturbed.
1. Yaffe K, Boustani M, Fairbanks RM. Benzodiazepines and risk of Alzheimer’s disease. BMJ
2014;349:g5312.
3. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for
Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen
Psychiatry 2006;63:530-8.
Article
Related content
Metrics
Responses
1. Kristine Yaffe, Roy and Marie Scola endowed chair and professor of psychiatry12,
2. Malaz Boustani, Richard M Fairbanks professor in aging research34
Author affiliations
1. Correspondence to: K Yaffe, 4150 Clement St, Box 181G, San Francisco, CA 94121,
USA [email protected]
Prescribers and patients need a proper surveillance system for cognitive side
effects
A growing number of observational studies have shown the critical role of potentially
inappropriate medications for increasing the risk of cognitive impairment. In a linked paper,
Billioti de Gage and colleagues (doi:10.1136/bmj.g5205) extend the pharmacoepidemiological
research on the adverse cognitive effects of benzodiazepines with an investigation of their link
with Alzheimer’s disease.1 Their results suggest that long term exposure to benzodiazepines
might be a modifiable risk factor for this condition.
The authors conducted a nested case-control study of about 2000 older members of a public drug
plan in the province of Quebec, Canada. They observed a cumulative dose-effect association
between exposure to benzodiazepines (at least 90 days) and risk of developing Alzheimer’s
disease and found that exposure lasting more than 180 days was associated with a nearly twofold
increase in risk. In further analyses, they showed that longer acting benzodiazepines were
associated with greater risk of developing Alzheimer’s disease compared with shorter acting
benzodiazepines, adding support for a causal association.
Article
Related content
Metrics
Responses
Related articles
Research
Benzodiazepine use and risk of Alzheimer’s disease: case-control study
Published: 09 September 2014; BMJ 349 doi:10.1136/bmj.g5205
https://www.healthline.com/health/what-is-a-psychotropic-drug#major-classes
What Is a Psychotropic
Drug?
Fast facts
Uses
Drug table
Major classes
Risks
Drug interactions
Legal issues
Emergency
Bottom line
A psychotropic describes any drug that affects behavior, mood, thoughts, or
perception. It’s an umbrella term for a lot of different drugs, including
prescription drugs and commonly misused drugs.
We’ll focus on prescription psychotropics and their uses here.
This is around 1 in 5 adults in the United States. More than 11 million reported
serious mental illness.
Mental health and well-being affect our daily lives. Psychotropic medications
can be an important part of the tools available to help keep us well.
anxiety
depression
schizophrenia
bipolar disorder
sleep disorders
aripiprazole (Abilify);
clozapine (Clozaril);
iloperidone (Fanapt);
olanzapine (Zyprexa);
Atypical antipsychotics
paliperidone (Invega);
quetiapine (Seroquel);
risperidone (Risperdal);
ziprasidone (Geodon)
alprazolam (Xanax);
clonazepam (Klonopin);
Anti-anxiety agents
diazepam (Valium);
lorazepam (Ativan)
citalopram (Celexa);
Selective serotonin reuptake inhibitor (SSRI) escitalopram (Lexapro);
antidepressants fluvoxamine (Luvox);
paroxetine (Paxil); sertraline (Zoloft)
atomoxetine (Strattera);
Serotonin-norepinephrine reuptake inhibitor (SNRI) duloxetine (Cymbalta);
antidepressants venlafaxine (Effexor XR); desvenlafaxine
(Pristiq)
isocarboxazid (Marplan);
phenelzine (Nardil);
Monoamine oxidase inhibitor (MAOI)
tranylcypromine (Parnate);
antidepressants
selegiline (Emsam, Atapryl, Carbex, Eldepryl,
Zelapar)
amitriptyline;
amoxapine;
desipramine (Norpramin); imipramine
Tricyclic antidepressants
(Tofranil);
nortriptyline (Pamelor); protriptyline (Vivactil)
Always talk to your doctor about the specific symptoms you’re experiencing.
They’ll find the best treatment options available to help you feel better.
Anti-anxiety agents
Side effects
dizziness
drowsiness
confusion
loss of balance
memory problems
low blood pressure
slow breathing
Caution
SSRI antidepressants
SSRIs are mainly used to treat different types of depression. Among them are
major depressive disorder and bipolar disorder.
Depression is more than feeling sad for a few days. It’s persistent symptoms
that last for weeks at time. You may also have physical symptoms, like sleep
issues, lack of appetite, and body aches.
Side effects
dry mouth
nausea
vomiting
diarrhea
poor sleep
weight gain
sexual disorders
Caution
Some SSRIs can cause elevated heart rate. Some can increase your risk for
bleeding if you’re also using blood thinning medications, such as nonsteroidal
anti-inflammatory drugs like aspirin or warfarin (Coumadin, Jantoven).
SNRI antidepressants
How they work
SNRIs help treat depression but work a bit differently than SSRIs. They
increase both dopamine and norepinephrine in the brain to improve
symptoms. SNRIs might work better in some people if SSRIs haven’t brought
improvement.
Side effects
headache
dizziness
dry mouth
nausea
agitation
sleep problems
appetite issues
Caution
These drugs can increase blood pressure and heart rate. Your liver function
must be monitored while on these medications as well.
MAOI antidepressants
These drugs are older and aren’t used very often today.
How they work
Side effects
nausea
vomiting
dizziness
diarrhea
dry mouth
weight gain
Caution
MAOIs taken with certain foods that have the chemical tyramine can increase
blood pressure to dangerous levels. Tyramine is found in many kinds of
cheese, pickles, and some wines.
Tricyclic antidepressants
These are one of the oldest classes of antidepressants still available on the
market. They’re reserved for use when newer medications haven’t been
effective.
How they work
Doctors also use tricyclics off-label to treat other conditions. Off-label use
means a drug is used for a condition that doesn’t have Food and Drug
Administration (FDA) approval for that condition.
panic disorder
migraine
chronic pain
obsessive-compulsive disorder
Side effects
dry mouth
dizziness
drowsiness
nausea
weight gain
Caution
glaucoma
enlarged prostate
thyroid issues
heart problems
These medications can raise blood sugar. If you have diabetes, you may have
to carefully monitor your sugar levels.
Typical antipsychotics
These drugs treat symptoms associated with schizophrenia. They may also
be used for other conditions.
Side effects
blurred vision
nausea
vomiting
trouble sleeping
anxiety
drowsiness
weight gain
sexual problems
Caution
tremors
uncontrolled facial movements
muscle stiffness
problems moving or walking
Atypical antipsychotics
bipolar disorder
depression
Tourette syndrome
Side effects
dizziness
constipation
dry mouth
blurred vision
weight gain
sleepiness
Caution
Mood stabilizers
Doctors use these drugs to treat depression and other mood disorders, like
bipolar disorder.
How they work
The exact way mood stabilizers work isn’t well understood yet. Some
researchers believe these medications calm specific areas of the brain that
contribute to the mood changes of bipolar disorder and related conditions.
Side effects
dizziness
nausea
vomiting
tiredness
stomach problems
Caution
The kidneys remove lithium from the body, so kidney function and levels of
lithium must be regularly checked. If you have poor kidney function, your
doctor may need to adjust your dose.
Stimulants
Stimulants increase dopamine and norepinephrine in the brain. The body can
develop dependence if used long term.
Side effects
Caution
Stimulants can increase heart rate and blood pressure. They may not be the
best option if you have heart or blood pressure problems.
Here are a few drugs and classes with boxed warnings. This isn’t a full list of
warnings. Always ask your doctor or pharmacist about specific drug side
effects and risks:
Aripiprazole (Abilify) and quetiapine (Seroquel) aren’t FDA approved for
use in anyone under age 18 due to the of risk suicidal thoughts and
behavior.
Antipsychotic medication use in older adults with dementia-related
psychosis can increase the risk of death.
Antidepressants can worsen suicidal thoughts and behavior in children
and adolescents.
Stimulant drugs may cause dependence and addiction.
Benzodiazepines taken with opioid medications can increase the risk of
overdose.
Clozapine (Clozaril) can cause agranulocytosis, a serious blood
disorder. You need to have blood work done to monitor your white blood
cell count. It can also cause seizures as well as heart and breathing
problems, which can be life threatening.
Avoid mixing psychotropic drugs with alcohol. Some classes, like BZDs,
antidepressants, and antipsychotic medications, have greater sedating effects
with alcohol. This can create problems with balance, awareness, and
coordination. It can also slow or stop breathing, which may be life threatening.
Drug interactions
Psychotropic drugs have many interactions with other drugs, food, alcohol,
and over-the-counter (OTC) products. Always tell your doctor and pharmacist
all the medications and supplements you’re taking to avoid adverse reactions.
SSRIs
SNRIs
MAOIs
tricyclics
lithium
Never share or sell your prescription medications. There are federal penalties
for selling or illegally buying these medications.
These medications can also cause dependence and lead to substance use
disorders.
If you or a loved one is at risk for self-harm, reach out to the National Suicide
Prevention Lifeline at 800-273-TALK for help.
For support and to learn more about substance use disorders, reach out to
these organizations:
They all work by adjusting neurotransmitter levels to help you feel better.
The medication your doctor prescribes depends on many factors, like your
age, other health conditions you may have, other medications you’re using,
and your past medication history.
Not all medications work right away. Some take time. Be patient, and talk to
your doctor if your symptoms are getting worse.
Discuss all treatment options, including cognitive behavioral therapy, with your
healthcare provider to develop the best care plan for you.
Last medically reviewed on November 6, 2019
9 sourcescollapsed
FEEDBACK:
We invest to shape a better future for the teachers we serve, the businesses
we back, the world we live in.
SPONSORED BY ONTARIO TEACHERS' PENSION...
See More
READ MORE
Medication Administration: Why
It’s Important to Take Drugs the
Right Way
Medically reviewed by Alan Carter, Pharm.D.
Medications are made to help us, but they can harm us if taken incorrectly.
Learn how drugs are administered and why it’s important to do it the right…
READ MORE
READ MORE
No, You Aren’t a Drug Addict If
You Take Antidepressants
Medically reviewed by Timothy J. Legg, PhD, PsyD
READ MORE
A drug rash or eruption is a type of drug reaction involving your skin. We'll go
over how to identify the different types and which ones require…
READ MORE
READ MORE
READ MORE
READ MORE
These medication reminders are all better than your average pillbox. From
apps to handheld timers, they make it easy to manage your medication…
READ MORE
Alcohol-based hand sanitizers can help keep you safe and reduce the spread
of germs if soap and water aren't available. It's also effective against…
READ MORE
Your privacy is important to us
About Us
Contact Us
AboutCareersAdvertise with us
OUR BRANDS
HealthlineMedical News TodayGreatistPsych Central
https://www.healthline.com/health/what-is-a-psychotropic-drug#legal-issues
https://www.webmd.com/mental-health/what-are-psychotropic-medications
IN THIS ARTICLE
How Psychotropic Medications Work
Types of Psychotropic Medications
Minimizing Complications
Psychotropic medications are used to treat mental health
disorders. There are five main types of psychotropic
medications, and each type has its own specific uses,
benefits, and side effects. Your doctor can help you decide
which psychotropic medication is right for you.
How Psychotropic Medications Work
Drowsiness
Insomnia
Constipation
Weight gain
Sexual problems
Tremors
Dry mouth
SUGGESTED
Nausea
Blurry vision
Headaches
Confusion
Fatigue
Nightmares
Insomnia
Decreased appetite
Weight loss
Drowsiness
Upset stomach
Increased appetite
Weight gain
Upset stomach
Drowsiness
Weight gain
Dizziness
Tremors
Blurry vision
Confusion
Minimizing Complications
Follow
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181628/
Go to:
Abstract
Several pharmacological treatments used in internal medicine can induce psychiatric side effects
(PSEs) that mimic diagnoses seen in psychiatry. PSEs may occur upon withdrawal or
intoxication, and also at usual therapeutic doses. Drugs that may lead to depressive, anxious, or
psychotic syndromes include corticosteroids, isotretinoin, levo-dopar mefloquine, interferon-a,
and anabolic steroids, as well as some over-the-counter medications. PSEs are often difficult to
diagnose and can be very harmful to patients. PSEs are discussed in this review, as well as
diagnostic clues to facilitate their identification.
Keywords: adverse effect, psychiatry, mechanism, risk
factor, diagnosis, mefloquine, chloroquine, metronidazole, isotretinoin, interferon, steroid, β-blocker
Psychiatric side effects (PSEs) can be Induced by the pharmacological treatment of physical
Illnesses. The clinical presentation of PSEs often resembles spontaneous psychiatric syndromes
(ie, noniatrogenic, naturally occurring diseases). PSEs can occur at usual doses, in cases of
intoxication, or during the days following withdrawal of a given treatment. PSEs range from
short-lasting anxiety to severe confusion, and alleged cases of suicide have even been reported.
The challenge of PSEs in everyday practice is the difficulty in recognizing these frequent and
potentially dangerous situations. The diagnosis of PSEs raises the same questions as the
diagnosis of any psychiatric sign or symptom, which means that the clinician has to consider a
rather long list of differential diagnoses.
The following concepts refer to PSEs, as well as to other kinds of side effects:
Exposure: The period of time the patient received the drug suspected of inducing a side effect.
Dechallenge: The interruption of the suspected medication, regardless of the remission of adverse
effects. Positive dechallenge means that remission was temporally associated with the interruption of
medication.
Rechallenge: The reintroduction of the suspected drug. Positive rechallenge means that symptom
reappearance was temporally associated with suspected drug réintroduction.
A drug can be considered to have a high probability of causing side effects in cases of positive
exposure, with a positive dechallenge and a positive rechallenge.
The importance of PSEs relates to the potential harm of these side effects and to their high
incidence. Two examples are reserpine and corticosteroids. Reserpine, when it was prescribed,
may have caused mood disorders in 10% of treated subjects. With corticosteroids, 6% of all
patients develop some PSEs.3
The focus of this review is on depression, anxiety, and psychotic states, but a few other PSEs are
also mentioned. A summary of the PSEs is presented and some examples are given in detail. In
addition, diagnostic issues are discussed to facilitate identification of PSEs in internal medicine.
PSEs secondary to psychotropic medication (such as antidepressants, anxiolytics, antipsychotics,
or mood-stabilizing agents) are not described here. They probably induce more PSEs than the
compounds quoted here, since they act directly on the nervous system.
Go to:
Mechanisms of PSEs
As with any side effect, pharmacological mechanisms are divided according to their
pharmacokinetic or pharmacodynamic nature. Patient-specific factors also lead to PSEs.
Pharmacodynamic mechanisms
Medications used in the treatment of physical disorders can modify neurotransmitter systems (as
do psychotropic medications). These modes of action can imply a direct influence on
neurotransmitters, as is the case for dopaminergic agents in the treatment of Parkinson's disease.
Interleukin (IL) treatment is another example where there is a direct influence, since interleukins
are involved in neurotransmission as well as in many other bodily functions. Other
nonpsychotropic medications influence neurotransmitter systems in a more indirect manner, such
as corticosteroids or sex steroids.
Pharmacokinetic mechanisms
Pharmacokinetic mechanisms are relevant when the PSE is known to follow a dose-response
curve. A low clearance represents the main pharmacokinetic mechanism inducing PSEs, ie, other
changes in the pharmacokinetics of drugs are of little relevance. Disease states, hepatic enzyme
polymorphisms, and drug interactions leading to metabolic inhibition are the main reasons for a
low clearance.
Interaction by metabolic inhibition is a general principle, applicable not only to PSEs, but also to
other side effects. Many drugs inhibit one or more pathways of hepatic metabolism. Cytochrome
P-450 (CYP450) enzymes metabolize endogenous as well as a variety of exogenous substrates,
such as toxins and drugs. Some drugs are metabolized by one metabolic pathway, others by
many When all metabolic pathways of a medication are inhibited, then the concentration of this
drug will rise, favoring the occurrence of side effects.
Antifungals can inhibit some metabolic pathways, including those of mefloquine, ie, the 3 A4
isoenzyme of CYP450.7 Mefloquine can rarely lead to serious PSEs at prophylactic doses,8,9 but
these risks are greater at high plasma concentrations.10 The prescription of a macrolide antibiotic
will probably raise concentrations of mefloquine, as most macrolides are 3A4 inhibitors. Hence,
serious PSEs can occur even at usual doses of both drugs.
Go to:
Risk factors
Patient-specific mechanisms of PSEs are more precisely defined as patient-related risk factors.
The risk factors for developing PSEs can be medication-related or patientrelated, as shown
in Table 1
Table I.
Risk factors for psychiatric side effects (PSEs).
Medication-related PSEs
Polypharmacy
High doses
Patient-related PSEs
Postpartum
Polypharmacy is one of the most important iatrogenic risk factors for PSEs, because of the
addition of pharmacological effects or due to metabolic inhibition. Addition of pharmacological
effects is illustrated by the concomitant prescription of clozapine and biperiden. These drugs are
both potent anticholinergics, so the risk of anticholinergic side effects is greater when they are
taken together than with each medication taken alone. Polypharmacy mimics a slow metabolizer
picture for many drugs, when hepatic metabolism is inhibited. There are many inhibitors of
hepatic metabolism: omeprazole, cimetidine, antifungals, antivirals, HMG-CoA (3-hydroxy-3-
methylglutaryl coenzyme A) reductase inhibitors (statins), antihypertensives, antiepileptics,
antidepressants, grapefruit juice, and many other compounds. It is practically impossible to
memorize all the CYP450 isoenzyme substrates, inhibitors, and inducers. Hence pocket
tables11 and software12,13 are useful for obtaining rapid information about such drug-drug
interactions, and potentially avoiding induction of PSEs. Many PSEs are dose-dependent, so
their risk increases with factors that raise the concentration of drugs. The CYP450 2D6
isoenzyme has absent or impaired activity in 7% of Caucasians14,15 and the 2C19 activity is
absent or impaired in as many as 12% to 22% of Asians.15
Go to:
Diagnosis and differential diagnosis
The diagnosis of PSEs can be challenging. The clinical pre_ sentations of depressive, anxious, or
psychotic PSEs meet most criteria of the DSM-IV for the corresponding spontaneous
(noniatrogenic) syndromes. Therefore, almost any psychiatric symptom or syndrome could be
considered as a potential PSE, until one has proven the contrary.
A simple case would be that of a peculiar or unusual psychiatric symptom, observed in a person
who has started (or interrupted) a medical treatment recently and has no history of a previous
psychiatric decompensation and no evident susceptibility to develop such a decompensation. A
difficult case would be that of a person who has already suffered from many decompensations of
psychiatric disorders and who develops a recurrence that presents itself clinically in a similar
manner as that known for the subject. In this case, a PSE can easily be overlooked, ie, the role of
a medical treatment as a relevant factor is difficult to identify Another case is that of a physical
disorder that can also induce psychiatric signs. For example, the clinician might not be able to
determine whether a case of depression relates to the patient's multiple sclerosis or to the
corticosteroid treatment. Another example would be a malaria patient treated with mefloquine
and presenting delirium: is the delirium due to the malaria rather than to the mefloquine?
The fact of being hospitalized for a severe physical illness constitutes a strain: in an intensive
care unit, the patient is exposed to pain, sleep deprivation, unusual environment, and threat of
disability or even death. In this context, it is difficult to distinguish reactive or drug-induced
psychological signs. Complex medical cases receive polypharmacy: some patients can receive
antiarrhythmics, bronchodilatators, analgesics, antibiotics, benzodiazepines, and other
medications. Among these complex situations, it can become practically impossible to determine
a single cause for a PSE. Yet, making such a diagnosis is necessary For example, in systemic
lupus erythematosus, the occurrence of PSEs can be due to corticosteroid treatment, but also to
the lupus cerebritis; the latter is associated with high levels of antibodies to P ribosomal proteins,
in both CSF and serum.16 This differential diagnosis is relevant, since the corticosteroid dose may
need to be increased.
The differential diagnoses of PSEs are summarized in Table II. History and chronology of drug
administration are first-line tools to diagnose a PSE. As already mentioned, an anamnesis with a
positive exposure, positive dechallenge, and positive rechallenge, indicates a high probability of
a causal link between a psychiatric sign and a prescribed medication.
Table II.
Differential diagnoses of psychiatric side effects (PSEs) of medications.
Underlying physical illnesses with psychiatric symptoms (eg, multiple sclerosis, systemic neoplasias,
electrolytic disturbances, lupus erythematosus)
Withdrawal-related PSEs. Side effects can occur after the discontinuation of antiparkinsonian agents,
benzodiazepines, antipsychotics, antidepressants, anabolic androgen steroids, etc
Intoxication-related PSEs
A PSE can differ from a spontaneous psychiatric syndrome in duration, since the duration of the
PSE is more linked to the presence or withdrawal of the offending agent. Once the incriminated
treatment is interrupted, behavioral symptoms usually remit within days to weeks, depending on
the half-life of the substance or the presence of a withdrawal syndrome. In complex cases of
polypharmacy, if the chronology of medication cannot help determine which medication caused
the side effect, a trial could be done by replacing one of the suspected drugs by another with a
lesser risk of PSEs.
Another issue about chronology concerns what can occur after interruption of treatment. This can
be illustrated by the case of an elderly male patient, who took St John's wort for 4 months, with
partial improvement of his depression. The dose was gradually increased, but without a complete
remission of the depression. Travel to an endemic zone of malaria was planned and mefloquine
prophylaxis was introduced. No side effect occurred during the first 10 days, until the clinician
decided to replace St John's wort by citalopram, without changes in the mefloquine prophylaxis.
The patient rapidly developed hallucinations after the introduction of citalopram. He had no
mental status changes when he received St John's wort and mefloquine, so the clinician stopped
citalopram. The hallucinations persisted. When mefloquine was discontinued, the hallucinations
remitted. The message is that even the interruption of a drug can lead to an increase in the
plasma concentrations of another drug, causing side effects. St John's wort Induces mefloquine
metabolism, which means that, In this case, mefloquine concentrations were lower while St
John's wort was given. Hallucinations are known side effects of mefloquine.
To improve the detection of PSEs, the physician should look for the anamnestic key factors listed
below:
The most useful complementary examination for PSE Investigation Is generally the monitoring
of plasma concentratlons of suspected medications. Monitoring of drug concentration Is
frequently performed for some drugs with high risk of toxicity, eg, digoxin, theophylline, or
lidocaine. Many other compounds can also be dosed in specialized laboratories.
If past analyses were performed for a given patient, they may also provide valuable clues. This
may apply even if different medications were measured. This occurs because an abnormally high
concentration of a medication may suggest a weak or absent metabolic pathway, as discussed in
the mechanisms section above. Knowledge of the patient's deficiencies in metabolism allows
avoidance of some PSEs by future prescriptions. Genotyping is a complementary examination to
detect polymorphisms of hepatic enzymes.
Go to:
Table III 3,8,9,17-197 gives a list of medications that might induce depression, mania, anxiety, or
psychotic syndromes (defined by delusions and/or hallucinations). This information is
qualitative, in the sense that the severity or the frequency of these side effects under each
medication or class is not indicated. Specific information can be found in the bibliography. Some
psychotropics, such as benzodiazepines, are listed in Table III because they are frequently
prescribed in internal medicine. Obviously, more than one of these PSEs can occur in a given
patient. For example, many depressive states are accompanied by anxiety Some clinically
relevant examples of medications presented In Table III are discussed below in more detail.
Table III.
Psychiatric side effects potentially induced by pharmacological treatment.
Depressio
Mania Anxiety Psychotic symptoms
n
Amantadine17,22 X X X X
Aminoglycosides23,24 X
Depressio
Mania Anxiety Psychotic symptoms
n
Amphetamines25-30 X X X X
Anabolic steroids31-33 X X X X
Anesthetics21,22,34,35 X X
Anticholinergics21,36-39 X X X
Antihistamines21,22,40 X X
Antitubercular agents22,41-45 X X X
Antivirals46-53 X X X
Baclofen22,54-58 X X X X
Barbiturates22,59 X X X X
Benzodiazepines21,22,60-62 X X X
β-Blockers21,22,63-72 X X X X
Bromocriptine21,73-77 X X X
Cephalosporins22,78-80 X X
Chloroquine81-88 X X X X
Clonidine21,22,113-115 X X X X
Corticosteroids3,21,22,94-112 X X X X
Digoxin21,22,113-115 X X X
Disulfiram21,22,116-118 X X X X
Interferon-α22,119-131 X X X X
Depressio
Mania Anxiety Psychotic symptoms
n
Isotretinoin22,132-137 X X
Levodopa21,22,138-152 X X X X
Lidocaine153-157 X X X X
Mefloquine8,9,22,158-160 X X X X
Methyldopa21,22 X X X
Methylphenidate22,161-163 X X X
Metoclopramide21,22,164-169 X X X
Metronidazole22,170-175 X
Opioids21,22,176-181 X X X X
Oral contraceptives21,22,182,183 X X
X
Procainamide21,184-188
Show more
Add to Mendeley
Share
Cite
Abstract
Psychiatric medications cause side effects in several organ systems that need
emergency evaluation and treatment. Serious cardiovascular side effects include
postural hypotension, cardiac conduction blockade, and SA mode dysfunction; serious
neurological side effects include extrapyramidal reactions, seizures, delirium,
catatonia, pseudotumor cerebri, ataxia, and glaucoma; serious genitourinary side
effects include urinary retention, nephrotic syndrome, and priapism, and the serious
hematological side effect of agranulocytosis. Also potentially fatal syndromes
secondary to psychiatric drugs are the neuroleptic malignant syndrome,
hyperandrenergic crisis, the serotonin syndrome, and lithium toxicity. Individual
psychiatric drug classes most notorious for causing side effects with high morbidity
and mortality are low potency neuroleptics, clozapine, tertiary tricyclics, monoamine
oxidase inhibitors, and lithium.
Previous article in issue
Next article in issue
Keywords
Drugs
emergencies
medications
side effects
reactions
psychiatric
psychotropic
Cited by (33)
Urological adverse drug reactions of psychotropic medication in psychiatric
inpatients – A drug surveillance report from German-speaking countries
Show abstract
Successful treatment of co-morbid schizophrenia and multiple sclerosis
Show abstract
Safety of trazodone as a sleep agent for inpatients
2005, Psychosomatics
Show abstract
A double-blind trial of risperidone and haloperidol for the treatment of
delirium
2004, Psychosomatics
Show abstract
Delirium
Show abstract
Clinical policy for the initial approach to patients presenting with altered
mental status
Show abstract
6.8.2022.
From
S.Karthikeyan,
110, old no.76, 2nd Street,
Kamaraj Avenue, Adyar,
Chennai-600020.
Cell:-9551011560.
To
Thiru.Ma.Subramanian,
Hon'ble Health Minister of Tamil Nadu,
Fort.St.George,
Secretariat, Chennai-600009.
Yours Sincerely,
S,Karthikeyan, Adyar, Chennai-20.
6.8.2022.
5 Attachments • Scanned by Gmail
to me
Your message couldn't be delivered to [email protected]. Their inbox is full, or it's getting too
much mail right now.
LEARN MORE
552 5.2.2 The email account that you tried to reach is over quota and inactive.
Please direct the recipient to https://support.google.com/mail/?p=OverQuotaPerm
c5-20020a170906924500b00722e1ac3ee8sor2384837ejx.110 - gsmtp
to me
LEARN MORE
552 5.2.2 The email account that you tried to reach is over quota and inactive.
Please direct the recipient to https://support.google.com/mail/?p=OverQuotaPerm
19-20020a170906319300b0072af119960esor2544841ejy.1 - gsmtp
4:16 PM (0 minutes ago)
Mail Delivery Subsystem <[email protected]>
to me
LEARN MORE
552 5.2.2 The email account that you tried to reach is over quota and inactive.
Please direct the recipient to https://support.google.com/mail/?p=OverQuotaPerm
19-20020a170906319300b0072af119960esor2544841ejy.1 - gsmtp